USCOM LIMITED — Regulatory Filings 2015

Nov 15, 2015

Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

M A R K E T A N N O U N C E M E N T

Uscom CEO Interviewed by Finance Guru Alan Kohler

SYDNEY, Australia, Monday 16th November 2015: Uscom Limited (ASX code: UCM) (the Company or Uscom ), a cardiovascular and pulmonary medical devices company, today released to the market the video interview of Uscom CEO Rob Phillips by the financial commentator Alan Kohler of News Limited for the Eureka Report.

Alan Kohler is one of Australia’s leading finance advisors and analysts being the Editor in Chief and Founder of the Eureka Report, Business Editor at Large for The Australian, Business Spectator, The Finance Presenter for the ABC News, and Adjunct Professor in Economics and Business at the Victoria University.

The Eureka Report is a subscription service for investors with particular emphasis on identifying Australian growth investment opportunities for Australian and overseas investors. The organisation provides research, analysis, economic review and wealth growth advice to subscribers.

The interview was wide ranging and dealt with Uscom corporate history, global biodevice industry trends, current Uscom technologies, corporate strategy, financial modelling, new product developments, the Thor acquisition, the US CPT Code and Uscom BP+, and operational questions on revenue, profitability and growth expectations. The interview can be accessed via the link set out at the end of this release.

Uscom manufactures and markets the USCOM 1A, the Uscom BP+, and the Uscom Thor digital ultrasonic spirometry technologies. These premium digital devices are changing the way we diagnose and treat cardiovascular and pulmonary diseases, including hypertension, heart failure, asthma, COPD and sleep disorders. The products are integral for optimising management of sepsis and guidance of fluid, inotropes and vasoactive therapies in critical care monitoring, and clinical and home care.

The Uscom Annual General Meeting will be held at the Uscom offices on Tuesday 24[th] November, 2015, at 11am.

References:

Interview of Uscom CEO Rob Phillips and Alan Kohler of the Eureka Report - www.uscom.com.au/blog/1455

Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

M A R K E T A N N O U N C E M E N T

About Uscom

Uscom Limited (UCM) is an ASX listed innovative medical technology company specialising in development and marketing of premium cardiovascular and pulmonary medical devices. Uscom has three practice leading suites of devices in the field of cardiac, vascular and pulmonary monitoring; the USCOM 1A, Uscom BP+ and the Uscom Thor Spirometers. All Uscom devices are premium quality, and deploy innovative and practice leading technologies with FDA, CE and TGA regulatory approval, and which are currently being marketed into global distribution networks.

The USCOM 1A is a simple to use, cost-effective and non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The USCOM 1A device has major applications in Paediatrics, Emergency, Intensive Care Medicine and Anaesthesia, and is the device of choice for management of adult and paediatric sepsis, hypertension, heart failure and for the guidance of fluid, inotrope and vasoactive cardiovascular therapy.

The Uscom BP+ is a supra systolic oscillometric Central Blood Pressure monitor which measures blood pressure and blood pressure waveforms only previously available using cardiac catheterisation. The Uscom BP+ replaces conventional and more widespread sub systolic blood pressure monitors, and is the emerging standard of care measurement in hypertension, heart failure and vascular health. The Uscom BP+ provides a highly accurate and repeatable measurement of central and brachial blood pressure and pulse pressure waveforms using a familiar upper arm cuff. The BP+ is simple to use and requires no complex training with applications in hypertension, heart failure, intensive care, general practice and home care.

Uscom Thor spirometers are high fidelity, digital, pulmonary function testing devices based on multi path ultrasound technology. They are simple and accurate to use and provide advanced pulmonary function testing in small hand held devices that can be used in research, clinical and home care environments. The devices are specialised for assessment of COPD, sleep disordered breathing, asthma and monitoring pulmonary therapeutic compliance.

For more information, please visit: www.uscom.com.au Uscom Contacts

Associate Professor Rob Phillips Executive Chairman rob@uscom.com.au

Catherine Officer Company Secretary secretary@uscom.com.au